PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Silo Pharma, Inc.
Filed: April 16, 2019
Period of Report: April 16, 2019
Accession Number: 0001213900-19-006476

View Document ↗ View on SEC.gov ↗